Form4insider filings, from the source

SEC Form 4 · accession 0001209191-17-063608

G1 Therapeutics, Inc. · GTHX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Clay Thorp
10% Owner
John Crumpler
10% Owner
Period of report
Nov 30, 2017
Accepted (ET)
Dec 4, 2017 · 5:01 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001560241

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2,F3,F4Nov 30, 2017J99,513$0.00D4,074,216ISee Footnotes
Common StockF5,F2,F3,F6Nov 30, 2017J995$0.00A4,075,211ISee Footnotes

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses